期刊文献+

Effect of growth hormone-releasing peptide on cardiac cholinergic nerve fiber density distribution in a rat model of heart failure

Effect of growth hormone-releasing peptide on cardiac cholinergic nerve fiber density distribution in a rat model of heart failure
下载PDF
导出
摘要 BACKGROUND: Changes in the cardiac autonomic nerve are considered to be important factors in the mechanisms of heart failure. It is possible to reduce or slow down nerve degeneration and necrosis, provided that patients take effective neuroprotectants during the early stages of heart failure. Moreover, it is possible to relieve the pathological process and reduce the risk of death. OBJECTIVE: To study the effect of growth hormone releasing peptide (GHRP) on cardiac cholinergic nerve fiber density distribution in a rat model of heart failure, and verify whether GHRP can ameliorate denervation. DESIGN, TIME AND SETTING: A randomized controlled study was performed at the Key Laboratory of Anatomy, Harbin Medical University, between June and October 2009. MATERIALS: Fifty adult, healthy, female, Wistar rats, weighing (200± 20) g, were randomly divided into GHRP (n = 30), model (n = 10), and sham operation (n = 10) groups. GHRP-2 was made in Shanghai, China (batch No. z071212-03). METHODS: Acute myocardial infarction was established by ligating the left anterior descending coronary artery in the GHRP and model groups. Five weeks later, myocardial function was detected using color ultrasound electrocardiograph a successful marker of chronic heart failure models Ejection fraction 〈 60% was considered to be However, the left anterior descending coronary artery was not ligated in the sham operation group. The GHRP group was injected with 100 μ g/kg GHRP-2, and the other two groups were injected with the same volume of physiological saline, once per day. MAIN OUTCOME MEASURES: After 4 weeks, pathological changes in cardiac cholinergic nerve fibers were detected under optic microscopy following hematoxylin/eosin staining. In addition, density distribution was measured using a multi-function color pathological image system. RESULTS: In the sham operation group, myocardial cells were regular, uniformly stained, and no inflammatory cells were present. In the model group, myocardial cells were unevenly stained, exhibited nuclear atrophy, degeneration, dissolution, or disappearance. In the GHRP group, myocardial damage was less than in the model group; cardiac muscle fibers exhibited slight degeneration. The myocardium in the sham operation group was serried, spreading the cholinergic innervations along the cardiac fiber. In the model group, there was a decreased number of cholinergic nerve fibers decreased, which also became shorter and smaller, compared with the sham operation group (P 〈 0.01). In the GHRP group, cholinergic positive nerve fibers were significantly increased compared with the model group (P 〈 0.01), but still less than the sham surgery group (P 〈 0.05). CONCLUSION: GHRP delayed denervation and reduced nerve reconstitution following heart failure in rats. BACKGROUND: Changes in the cardiac autonomic nerve are considered to be important factors in the mechanisms of heart failure. It is possible to reduce or slow down nerve degeneration and necrosis, provided that patients take effective neuroprotectants during the early stages of heart failure. Moreover, it is possible to relieve the pathological process and reduce the risk of death. OBJECTIVE: To study the effect of growth hormone releasing peptide (GHRP) on cardiac cholinergic nerve fiber density distribution in a rat model of heart failure, and verify whether GHRP can ameliorate denervation. DESIGN, TIME AND SETTING: A randomized controlled study was performed at the Key Laboratory of Anatomy, Harbin Medical University, between June and October 2009. MATERIALS: Fifty adult, healthy, female, Wistar rats, weighing (200± 20) g, were randomly divided into GHRP (n = 30), model (n = 10), and sham operation (n = 10) groups. GHRP-2 was made in Shanghai, China (batch No. z071212-03). METHODS: Acute myocardial infarction was established by ligating the left anterior descending coronary artery in the GHRP and model groups. Five weeks later, myocardial function was detected using color ultrasound electrocardiograph a successful marker of chronic heart failure models Ejection fraction 〈 60% was considered to be However, the left anterior descending coronary artery was not ligated in the sham operation group. The GHRP group was injected with 100 μ g/kg GHRP-2, and the other two groups were injected with the same volume of physiological saline, once per day. MAIN OUTCOME MEASURES: After 4 weeks, pathological changes in cardiac cholinergic nerve fibers were detected under optic microscopy following hematoxylin/eosin staining. In addition, density distribution was measured using a multi-function color pathological image system. RESULTS: In the sham operation group, myocardial cells were regular, uniformly stained, and no inflammatory cells were present. In the model group, myocardial cells were unevenly stained, exhibited nuclear atrophy, degeneration, dissolution, or disappearance. In the GHRP group, myocardial damage was less than in the model group; cardiac muscle fibers exhibited slight degeneration. The myocardium in the sham operation group was serried, spreading the cholinergic innervations along the cardiac fiber. In the model group, there was a decreased number of cholinergic nerve fibers decreased, which also became shorter and smaller, compared with the sham operation group (P 〈 0.01). In the GHRP group, cholinergic positive nerve fibers were significantly increased compared with the model group (P 〈 0.01), but still less than the sham surgery group (P 〈 0.05). CONCLUSION: GHRP delayed denervation and reduced nerve reconstitution following heart failure in rats.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第4期271-275,共5页 中国神经再生研究(英文版)
基金 Supported by:the Natural Science Foundation of Heilongjiang Province,No. D2006-24 Post-graduate Scientific and Technological Innovation Program of Heilongjiang Province,No. YJSCX2007-0077HLJ Research Fund of Heilongjiang Provincial Education Department,No. 11511241 Scientific Research Fund of Heilongjiang Provincial Education Department,No. 11531386
关键词 growth hormone releasing peptide heart failure cholinergic nerve nerve fiber growth hormone releasing peptide heart failure cholinergic nerve nerve fiber
  • 相关文献

参考文献1

二级参考文献34

  • 1King MK, Gay DM, Pan LC, et al. Treatment with a growth hormone secretagogue in a model of developing heart failure. Effect on ventricular and myocyte function[J]. Circulation, 2001, 103: 308-313.
  • 2Li Z, Bing OH, Long X, et al. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat[J]. Am J Physiol, 1997, 272: H2313-2319.
  • 3Levine B. Kalman J. Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[J]. N Engl J Med, 1990, 323:263-241.
  • 4Ferrari R. Bachetti T. Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of chronic heart failure[J]. Circulation, 1995, 92:1479-1486.
  • 5Van Deuren M. Dofferhoff ASM. Van der Meer JWM. Cytokines and the response to infection[J]. J Pathol, 1992, 168:349-356.
  • 6Torre-Amione G. Kappadia S. Lee J, et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium[J]. Circulation, 1995, 92:1487-1493.
  • 7Deswal A. Bozkurt B. Yukihiro S, et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, Etanercept) in patients with advanced heart failure[J]. Circulation, 1999, 99:3224-3226.
  • 8Mathews LS, Enberg B, Norstedt G. Regulation of rat growth hormone receptor gene expression[J]. J Biol Chem, 1989, 17:9905-9910.
  • 9Wahlander H, Isgard J, Jeunishe E, et al. Left ventricular insulin like growth factor Ⅰ increases in early renal hypertension[J]. Hypertension, 1992, 19: 25-32.
  • 10Valetto MR, Podio V, Broglio F, et al. The acute administration of Hexarelin, a peptidal GH secretagogoues, has GH-independent positive inotropic effect in humans[A]. Hormones and the heart[M]. Italy: Naples, 1998. 54.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部